Dynamic Pharmacodynamic Modeling Focused on the Protein Kinase a Signaling Pathway. (Paperback)


A simple mechanism-based pharmacodynamic (PD) model focused on the protein kinase A (PKA) pathway has been conceived in an attempt to understand covariates associated with PD variability. In this model, one possible physiological mechanism underlying variabilities in the apparent Hill coefficient variability is postulated. Variabilities in the levels of effector signaling molecules, whose activation and inactivation processes are governed by the interplay of kinases and phosphatases, may lead to variability in the Hill coefficient. Methods. Simulations. A simple mathematical model describing the PKA pathway, with kinase and phosphatase counterpoint, regulating the phosphorylation state (phospho-state) of an effector molecule, was studied. Dose response profiles under different cellular conditions were simulated using MatlabRTM, and parameters of the traditional Emax model (Hill coefficients, Emax and EC50) were matched to the simulated dose response curves. An auxiliary model of drug tolerance, in which steadily expressed effector is degraded at different rates depending on its phospho-state, was also investigated, and predictions are made regarding tolerance effects on drug efficacy, potency, and sensitivity. Experimental methods. Activated PKA is known to migrate to various regions of the cell and phosphorylates numerous cellular components, including the cAMP response element binding (CREB) protein in the nucleus, which in turn acts as a transcription factor, turning on genes coding for diverse proteins. To investigate the effect of overall level of CREB on the Hill coefficient of the drug response curve (conversion of CREB to pCREB) for the model drug forskolin (a direct stimulator of adenylyl cyclase) was measured. CREB plasmids were transfected into both Human Embryonic Kidney and Madin-Darby Canine Kidney cells. Levels of pCREB were measured using three different assays: immunofluorescence, immunoblotting and cellular enzyme-linked immunosorbent assay. Results and conclusions. Simulations showed that the level of effector signaling molecules influenced significantly on Hill coefficient of phosphorylation of effector. Although parameter estimation was not feasible with the data obtained from experiments, likelihood of the effect of CREB on Hill coefficient of phosphorylation of CREB was observed, rendering a leeway for future studies.

R2,052

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles20520
Mobicred@R192pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

A simple mechanism-based pharmacodynamic (PD) model focused on the protein kinase A (PKA) pathway has been conceived in an attempt to understand covariates associated with PD variability. In this model, one possible physiological mechanism underlying variabilities in the apparent Hill coefficient variability is postulated. Variabilities in the levels of effector signaling molecules, whose activation and inactivation processes are governed by the interplay of kinases and phosphatases, may lead to variability in the Hill coefficient. Methods. Simulations. A simple mathematical model describing the PKA pathway, with kinase and phosphatase counterpoint, regulating the phosphorylation state (phospho-state) of an effector molecule, was studied. Dose response profiles under different cellular conditions were simulated using MatlabRTM, and parameters of the traditional Emax model (Hill coefficients, Emax and EC50) were matched to the simulated dose response curves. An auxiliary model of drug tolerance, in which steadily expressed effector is degraded at different rates depending on its phospho-state, was also investigated, and predictions are made regarding tolerance effects on drug efficacy, potency, and sensitivity. Experimental methods. Activated PKA is known to migrate to various regions of the cell and phosphorylates numerous cellular components, including the cAMP response element binding (CREB) protein in the nucleus, which in turn acts as a transcription factor, turning on genes coding for diverse proteins. To investigate the effect of overall level of CREB on the Hill coefficient of the drug response curve (conversion of CREB to pCREB) for the model drug forskolin (a direct stimulator of adenylyl cyclase) was measured. CREB plasmids were transfected into both Human Embryonic Kidney and Madin-Darby Canine Kidney cells. Levels of pCREB were measured using three different assays: immunofluorescence, immunoblotting and cellular enzyme-linked immunosorbent assay. Results and conclusions. Simulations showed that the level of effector signaling molecules influenced significantly on Hill coefficient of phosphorylation of effector. Although parameter estimation was not feasible with the data obtained from experiments, likelihood of the effect of CREB on Hill coefficient of phosphorylation of CREB was observed, rendering a leeway for future studies.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Proquest, Umi Dissertation Publishing

Country of origin

United States

Release date

September 2011

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

September 2011

Authors

Dimensions

254 x 203 x 13mm (L x W x T)

Format

Paperback - Trade

Pages

194

ISBN-13

978-1-243-45976-3

Barcode

9781243459763

Categories

LSN

1-243-45976-X



Trending On Loot